Clearbridge Health Ltd Share Price Singapore S.E.
Equities
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- SGD | - |
29/04 | Clearbridge Health Awards Shares Under Performance Share Plan | MT |
29/02 | Clearbridge Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 16.41M 12.16M 1.01B | Sales 2023 | 11.49M 8.52M 710M | Capitalization | 9.9M 7.34M 612M |
---|---|---|---|---|---|
Net income 2022 | -11M -8.15M -679M | Net income 2023 | -32M -23.72M -1.98B | EV / Sales 2022 | 1.49 x |
Net Debt 2022 | 913K 677K 56.39M | Net Debt 2023 | 2.5M 1.85M 155M | EV / Sales 2023 | 1.08 x |
P/E ratio 2022 |
-2.11
x | P/E ratio 2023 |
-0.31
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 53.05% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Yee
CEO | Chief Executive Officer | 54 | 15/17/15 |
Wei Chee Tan
AUD | Comptroller/Controller/Auditor | 39 | 01/22/01 |
Hui Yee Cheok
SEC | Corporate Secretary | - | 24/22/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeremy Yee
CEO | Chief Executive Officer | 54 | 15/17/15 |
Mark Ryan
BRD | Director/Board Member | 57 | 20/17/20 |
Andrew Lord
BRD | Director/Board Member | 65 | 20/17/20 |
1st Jan change | Capi. | |
---|---|---|
+14.31% | 81.68B | |
-28.96% | 69.23B | |
+9.72% | 29.08B | |
-11.64% | 16.88B | |
-0.43% | 16.85B | |
-1.02% | 15.15B | |
+3.42% | 12.62B | |
+29.00% | 12.47B | |
-30.70% | 11.89B |